Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial

• Published in: BMC complementary and alternative medicine 2011-02, Vol.11 (1), p.15-15, Article 15
• Main Authors: Matsumoto, Keiji, Yamada, Hiroshi, Takuma, Norikata, Niino, Hitoshi, Sagesaka, Yuko M
• Format: Article
• Language: English
• Subjects: Adult; Camellia sinensis - chemistry; Catechin; Catechin - therapeutic use; Chemical properties; Clinical trials; Confidence intervals; Design; Double-Blind Method; Etiquette; Glutamates - therapeutic use; Green tea; Health aspects; Health facilities; Health Personnel; Humans; Incidence; Influenza; Influenza, Human - epidemiology; Influenza, Human - prevention & control; Intervention; Logistics; Medical personnel; Medicine, Botanic; Medicine, Herbal; Mortality; Nursing; Phytotherapy; Plant Extracts - chemistry; Plant Extracts - therapeutic use; Prevention; Regression analysis; Studies; Tea; Theanine
• ISSN: 1472-6882; 1472-6882
• DOI: 10.1186/1472-6882-11-15

Experimental studies have revealed that green tea catechins and theanine prevent influenza infection, while the clinical evidence has been inconclusive. This study was conducted to determine whether taking green tea catechins and theanine can clinically prevent influenza infection. A randomized, double-blind, placebo-controlled trial of 200 healthcare workers conducted for 5 months from November 9, 2009 to April 8, 2010 in three healthcare facilities for the elderly in Higashimurayama, Japan. The catechin/theanine group received capsules including green tea catechins (378 mg/day) and theanine (210 mg/day). The control group received placebo. The primary outcome was the incidence of clinically defined influenza infection. Secondary outcomes were (1) laboratory-confirmed influenza with viral antigen measured by immunochromatographic assay and (2) the time for which the patient was free from clinically defined influenza infection, i.e., the period between the start of intervention and the first diagnosis of influenza infection, based on clinically defined influenza infection. Eligible healthcare workers (n = 197) were enrolled and randomly assigned to an intervention; 98 were allocated to receive catechin/theanine capsules and 99 to placebo. The incidence of clinically defined influenza infection was significantly lower in the catechin/theanine group (4 participants; 4.1%) compared with the placebo group (13 participants; 13.1%) (adjusted OR, 0.25; 95% CI, 0.07 to 0.76, P = 0.022). The incidence of laboratory-confirmed influenza infection was also lower in the catechin/theanine group (1 participant; 1.0%) than in the placebo group (5 participants; 5.1%), but this difference was not significant (adjusted OR, 0.17; 95% CI, 0.01 to 1.10; P = 0.112). The time for which the patient was free from clinically defined influenza infection was significantly different between the two groups (adjusted HR, 0.27; 95% CI, 0.09 to 0.84; P = 0.023). Among healthcare workers for the elderly, taking green tea catechins and theanine may be effective prophylaxis for influenza infection. ClinicalTrials (NCT): NCT01008020.